Sotsiaalministeerium · 19. september 2018
Sisu (failidest)
Dear
Colleague,
We
are
inviting
you
to
join
an
initiative
to
protect
the
integrity
of
specialist
physicians’
CME/CPD.
Recent
publications
have
attempted
to
promote
the
role
of
industry
in
the
provision
of
CME
for
specialists.
We
believe
this
should
be
resisted.
Following
medical
studies
and
specialty
training
working
as
a
specialist
comprises
the
longest
time
period
in
a
physician’s
life.
Hence
continuing
education
and
professional
development
are
cornerstones
to
achieve
maintenance
and
adaptation
of
professional
competence
to
contemporary
requirements.
Physicians
have
committed
themselves
to
focus
in
this
process
on
the
best
interest
of
their
patients,
and
in
particular
to
make
their
judgements
and
recommendations
independent
from
third
party
interests.
With
regard
to
Continuing
Medical
Education
(CME)-‐
Continuing
Professional
Development
(CPD)
there
is
an
on-‐going
discussion
on
how
to
preserve
independence
of
CME-‐CPD
from
commercial
interests.
Unlike
the
situation
in
North
America,
where
two
organisations
cover
the
whole
subcontinent,
the
situation
in
Europe
is
characterised
by
greater
fragmentation.
Thus,
the
newly
formed
association
of
independent
European
accreditors
(CME-‐EA)
aims
to
promote
a
European
consensus
on
independence
of
CME-‐CPD,
endorsed
by
all
organisations
involved
in
defining
the
framework
for
CME-‐CPD
in
their
country,
to
demonstrate
that,
although
working
under
diverse
legal
frameworks,
physicians
in
Europe
all
still
belong
to
one
profession,
sharing
the
same
principles
and
values.
For
this
purpose
CME-‐EA
has
drafted
a
position
paper
on
independence
in
CME-‐CPD,
to
be
published
in
the
major
journal
dealing
with
CME-‐CPD
issues,
and
we
would
like
to
ask
you
to
consider
becoming
a
co-‐author
of
this
publication
in
order
to
ensure
the
widest
possible
consensus.
Please
consider
this
a
draft
for
discussion,
and
feel
free
to
enter
your
comments
as
well
as
bibliography
relevant
to
your
country.
Having
received
your
contributions
and/or
comments,
we
intend
to
convene
all
contributors
and
discuss
the
final
version
of
the
paper
in
a
live
meeting
later
the
year.
CME-‐EA
e.V.,
c/o
EBAC
GmbH,
Schanzenstr.
36,
Geb.
31a,
D-‐51063
Koeln
Let
your
voice
be
heard!
Yours
Fabiola
de
Andrade,
MA
Prof.
Reinhard
Griebenow,
MD,
PhD
Chair,
CME-‐EA
Vice-‐chair,
CME-‐EA
CME-‐EA
e.V.,
c/o
EBAC
GmbH,
Schanzenstr.
36,
Geb.
31a,
D-‐51063
Koeln
Dear Dr. Jesse,
recent activities from industry to become recognised as providers in accredited CME-CPD need a
joint response from European organisations involved in accreditation of CME-CPD on the
national as well as international level. CME-EA has started to facilitate and moderate this process
by preparing a draft position paper, and would like to invite your organisation to contribute as
co-author to the final version, to be published in national as well as international media (please
see attachments to this invitation).
Thus, on behalf of CME-EA we would like to invite you to a live meeting to take place at the
premises of the German Medical Association on
October 31st, 2018, 11am-4pm
Bundesärztekammer
Herbert–Lewin-Platz 1
10623 Berlin
(near S-train station “Tiergarten”)
The invitation primarily reaches out to accreditation bodies. In case that CME accreditation has
not been implemented on the national level, organisations in charge of defining professional
standards have been invited. If this should not relate to your organisation, we would be grateful,
if you could pass the invitation to those in charge or most interested in this matter.
Looking forward to meet you in Berlin we remain
With best regards
Fabiola de Andrade Prof. Reinhard Griebenow,MD
Chair, CME-EA Vice-chair, CME-EA
P.S. Please note: cost for travel and accommodation have to be covered by your organisation, a
buffet lunch will be provided. For planning purposes we kindly ask you to let us know in advance
how many members of your organisation are going to attend.
Position paper
Independent Continuing Medical Education
(CME)/Continuing Professional Development (CPD)
means at first independent information
Authors: European accreditation bodies
(national/international)
Physicians have committed themselves to always act in the best
interest of their patients (1), this includes their approach to
continuing medical education (CME) as well as continuing
professional development (CPD) which are cornerstones for the
maintenance of professional competence (MOC). For many years
professional codes, and in some countries also the (professional)
law, have defined that CME/CPD must be independent of
commercial interests (1, EU-national).
Over the last few decades numerous national bodies have
introduced CME/CPD accreditation to ensure that the planning
and conduct of CME/CPD follows a set of defined standards, with
independence of commercial interests as one of the leading
principles (EU-national, 2, 3).
In Europe, this is augmented by an additional type of accreditor,
the European international accreditor. These accreditors include
members of CME-EA, EACCME and other organisations and are
devoted to accreditation of CME/CPD activities in Europe that
have primarily international attendance.
However, accreditation has little value in and on its own, it is
almost entirely dependent on having clear and transparent
definitions, rigorous application of appropriate principles and
rules, and being in the position to enforce its own standards.
With regard to enforcement , only a few European national
accreditation systems are officially legitimated by national
jurisdictions (e.g. DE, AT, IT). This enables the accreditor to
impose accreditation on all providers nationwide (but vice-versa
also imposing legal liability on the accreditor).
But still many accreditors in Europe (including all European
international accreditors) are institutions based on civil law, and
thus lack official legitimation.
Despite the sometimes uncertain legal basis CME/CPD
accreditation still serves as an important component of quality
assurance in medicine. Accreditation safeguards the credibility of
the medical profession in one of the most important areas in
medicine, i.e. maintenance of our intellectual basis in medical
decision-making by life-long learning. Thus, irrespective of the
variable legal status, accreditors will only be able to convince the
(medical) public, and prove their legitimacy by comprehensible
and rigorous application of their transparent principles and rules.
All major accreditation systems grant accreditation prior to the
start of the CME/CPD activity. This implies that accreditation
relies on professional honesty, and self-commitment of the
medical professionals involved in delivery of CME/CPD, to align
their presentations with the principles and rules as outlined by
the accreditor.
There are several key principles in medical education to be
followed by providers (which should also be used by participants
to evaluate a given CME/CPD activity):
It all starts with independence of information itself as well as
independence of interpretation of information in the appropriate
clinical context. Other criteria like educational efficacy of a
CME/CPD activity are of secondary importance in light of the
fundamental bias introduced by use of framed information in life-
long learning.
Fully transparent and timely provision of data can obviously
collide with the commercial interests of industry (4, 5, 6), as
driven by the market economy’s framework set by governments
in most developed countries. This limitation weighs even more in
the light of the fact that currently about 80% of all trial patients
are in clinical trials sponsored by industry (7).
Whilst the development and provision of drugs and devices
continues to follow the fundamental principles of a market
economy with its inbuilt difficulties of accessing information, then
if we were to accept industry as a provider of accredited
CME/CPD, as recently proposed in the Journal (8), then we would
open the door for the introduction of an inevitable bias in
CME/CPD. It is for this reason that major accreditors have
recently reiterated in a global consensus document that “the
content, as well as persons and organizations in control of the
content, of the accredited CME/CPD activity is developed/selected
independently, with no influence, control or involvement from a
commercial interest...” (9).
Many accreditors go one step further by defining the details of
communication to participants to avoid any misperceptions with
regard to promotion (10, EU-national), in particular in sponsored
CME/CPD.
Accreditors are well aware that in CME/CPD there are further
threats to independent alignment of evidence with current
strategies in diagnosis and treatment of particular conditions
(interpretation), and discussion on how to apply evidence in the
individual patient (implementation):
- This includes a long list of (potential conflicts of) interests,
including issues related to career development and/or
welfare of individuals involved in planning and delivery of
CME, but also institutional interests e.g. of hospital owners,
insurance companies etc. Thus, fully transparent
communication of interests to participants in CME/CPD as
well as management of the conflicts of interest are
indispensable supportive strategies in planning and delivery
of independent CME/CPD, but they can never outweigh the
negative effects of information compromised by commercial
interests. This also applies to the principles of evidence
based medicine, whose practice has been further facilitated
by development of elaborate methods for post-processing of
information to design tools to support clinical decision-
making by recommendations based on grading of the
strength of evidence (11), or by provision of systematic
reviews and meta-analyses (12). Major accreditors
recommend the systematic use of these tools in the provision
of accredited CME/CPD (EU-national, -international).
However, the value of such tools also critically depends on
timely and complete availability of data to obtain a realistic
estimate of benefit-risk ratios of diagnostic and/or
therapeutic interventions.
- CME/CPD should always be designed to help participants to
close gaps in knowledge and/or professional performance.
The underlying gap analysis as well as definition of “learning
objectives” mark another area, in which commercial
interests should never be involved to avoid direct agenda
setting by industry, although accreditors are well aware that
indirect agenda setting currently occurs by allocation of
sponsoring: Evidence is available that CME with industry
involvement has a narrower range of topics and more
product-related content than CME without direct industry
involvement even when funding is unrestricted (13).
The primary importance of independence in accreditation should
not override the consideration of the role of different educational
formats for the delivery of effective CME/CPD. Although overall
educational quality may be considered as satisfactory (EU-
national, -international), accreditors have always wanted to
stimulate improvement, as demonstrated by initiatives to
stimulate providers to further develop their educational formats
(EU-national, -international).
CME/CPD accreditation has been designed to mark the difference
between independent, strictly evidence based CME/CPD and
interest driven CME/CPD. If there were to be no differences in
requirements for independence any more, accreditation alone will
not be able to resolve the issue and may be seen as no longer
needed.
In certain jurisdictions (Germany, 14) commercially driven
CME/CPD may also be considered as providing inadequate
independence in influencing opinion formation, and decision-
making. This mixing up of CME/CPD with commercial interests
may introduce further difficulties with differentiating medical
education from advertising.
Accreditation of CME/CPD currently serves several different
purposes, but its fate will be decided by whether it can retain its
ability to differentiate independent CME/CPD from provision of
commercially framed information.
References
1. World Medical Association Declaration of Geneva,
accessed on Jan. 18th, 2018: https://www.wma.net/policies-
post/wma-declaration-of-geneva/
2. ACCME Standards for Commercial Support: Standards to
Ensure Independence in CME Activities
Accessed on Jan. 18th, 2018:
http://www.accme.org/requirements/accreditation-
requirements-cme-providers/standards-for-commercial-
support
3. National Standard for Support of Accredited CPD Activities
Accessed on Jan. 18th, 2018:
http://www.royalcollege.ca/rcsite/cpd/providers/tools-
resources-accredited-cpd-providers/national-standard-
accredited-cpd-activities-e
4. Köhler M, Haag S, Biester K, et al. Information on new drugs
at market entry: retrospective analysis of health technology
assessment reports versus regulatory reports, journal
publications, and registry reports. Bmj. 2015;350:h796.
5. Anderson ML, Chiswell K, Peterson ED, et al. Compliance
with results reporting at clinical trials.gov. N Engl J Med.
2015;372:1031–1039.
6. European Medicines Agency: Clinical Trial Regulation
Accessed on Jan. 18th, 2018:
http://www.ema.europa.eu/ema/index.jsp?curl=pages/regu
lation/general/general_content_000629.jsp
7. Flacco ME, Manzoli L, Boccia S, et al. Head-to-head rando-
mized trials are mostly industry sponsored and almost
always favor the industry sponsor. J Clin Epidemiology.
2015;68:811–820.
8. Tamara Allen, Nina Donde, Eva Hofstädter-Thalmann, Sandra
Keijser, Veronique Moy, Jean-Jacques Murama & Thomas
Kellner (2017) Framework for industry engagement and
quality principles for industry-provided medical education in
Europe, Journal of European CME, 6:1, 1348876, DOI:
10.1080/21614083.2017.1348876
9. International Academy for CPD Accreditation:
Consensus Statement for Independence and Funding of
Continuing Medical Education (CME)/ Continuing
Professional Development
Accessed on Jan. 18th, 2018:
https://academy4cpdaccreditation.files.wordpress.com/201
8/01/consensus-statement-for-independence-and-funding-
of-cme_cpd_final.pdf
10. Daiana Stolz, Reinhard Griebenow, Andre Tichelli,
Andrew J. Ullmann, Richard Costello, Lampros Michalis,
Margarita Guenova, Sandy Sutter, Fabiola De Andrade &
Robert Schaefer (2017) Position paper on current aspects of
sponsoring in accredited CME, Journal of European CME, 6:1,
1312062, DOI: 10.1080/21614083.2017.1312062
11. The Grading of Recommendations Assessment,
Development and Evaluation (GRADE) working group
Accessed on Jan. 18th, 2018:
http://www.gradeworkinggroup.org
12. Cochrane Library
Accessed on Jan. 18th, 2018:
http://www.cochranelibrary.com
13. Katz HP, Goldfinger SE, Fletcher SW. Academia-industry
collaboration in continuing medical education: description of
two approaches. J Contin Educ Health Prof. 2002;22(1):43–54.
14. Gesetz zur Bekämpfung von Korruption im
Gesundheitswesen (Law against corruption in the health-
care system)
Accessed on Jan. 18th, 2018:
https://www.bmjv.de/SharedDocs/Gesetzgebungsverfahren
/Dokumente/BGBl_Bekaempfung_Korruption_Gesundheitsw
esen.pdf?__blob=publicationFile&v=3